• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在疫苗供应有限的情况下,埃塞俄比亚 COVID-19 疫苗接种的优先年龄目标。

Priority age targets for COVID-19 vaccination in Ethiopia under limited vaccine supply.

机构信息

Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.

Department of Mathematics, Computer Science and Physics, University of Udine, Udine, Italy.

出版信息

Sci Rep. 2023 Apr 5;13(1):5586. doi: 10.1038/s41598-023-32501-y.

DOI:10.1038/s41598-023-32501-y
PMID:37019980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10075159/
Abstract

The worldwide inequitable access to vaccination claims for a re-assessment of policies that could minimize the COVID-19 burden in low-income countries. Nine months after the launch of the national vaccination program in March 2021, only 3.4% of the Ethiopian population received two doses of COVID-19 vaccine. We used a SARS-CoV-2 transmission model to estimate the level of immunity accrued before the launch of vaccination in the Southwest Shewa Zone (SWSZ) and to evaluate the impact of alternative age priority vaccination targets in a context of limited vaccine supply. The model was informed with available epidemiological evidence and detailed contact data collected across different geographical settings (urban, rural, or remote). We found that, during the first year of the pandemic, the mean proportion of critical cases occurred in SWSZ attributable to infectors under 30 years of age would range between 24.9 and 48.0%, depending on the geographical setting. During the Delta wave, the contribution of this age group in causing critical cases was estimated to increase on average to 66.7-70.6%. Our findings suggest that, when considering the vaccine product available at the time (ChAdOx1 nCoV-19; 65% efficacy against infection after 2 doses), prioritizing the elderly for vaccination remained the best strategy to minimize the disease burden caused by Delta, irrespectively of the number of available doses. Vaccination of all individuals aged ≥ 50 years would have averted 40 (95%PI: 18-60), 90 (95%PI: 61-111), and 62 (95%PI: 21-108) critical cases per 100,000 residents in urban, rural, and remote areas, respectively. Vaccination of all individuals aged ≥ 30 years would have averted an average of 86-152 critical cases per 100,000 individuals, depending on the setting considered. Despite infections among children and young adults likely caused 70% of critical cases during the Delta wave in SWSZ, most vulnerable ages should remain a key priority target for vaccination against COVID-19.

摘要

全球在疫苗接种方面存在不平等现象,这要求我们重新评估政策,以尽量减少低收入国家的 COVID-19 负担。2021 年 3 月国家疫苗接种计划启动九个月后,埃塞俄比亚只有 3.4%的人口接种了两剂 COVID-19 疫苗。我们使用 SARS-CoV-2 传播模型来估计在西南Shewa 地区(SWSZ)启动疫苗接种之前获得的免疫水平,并评估在疫苗供应有限的情况下,替代年龄优先接种目标的影响。该模型以现有的流行病学证据和在不同地理环境(城市、农村或偏远地区)收集的详细接触数据为依据。我们发现,在大流行的第一年,SWSZ 中 30 岁以下感染者导致的重症病例比例平均值将在 24.9%至 48.0%之间,具体取决于地理环境。在 Delta 波期间,据估计,该年龄段导致重症病例的比例平均增加到 66.7-70.6%。我们的研究结果表明,在考虑当时可获得的疫苗产品(ChAdOx1 nCoV-19;两剂后对感染的 65%效力)时,为老年人接种疫苗仍然是最大限度减少 Delta 造成的疾病负担的最佳策略,无论可用剂量多少。为所有≥50 岁的人接种疫苗将分别避免每 10 万人中有 40 例(95%置信区间:18-60)、90 例(95%置信区间:61-111)和 62 例(95%置信区间:21-108)重症病例,分别为城市、农村和偏远地区。为所有≥30 岁的人接种疫苗将平均避免每 10 万人中有 86-152 例重症病例,具体取决于所考虑的环境。尽管在 SWSZ 的 Delta 波期间,儿童和年轻人中的感染可能导致了 70%的重症病例,但最脆弱的年龄群体仍应成为 COVID-19 疫苗接种的重点目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/10076294/c3a32e4f21e9/41598_2023_32501_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/10076294/5f23e23ad6e8/41598_2023_32501_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/10076294/2f6b115bae80/41598_2023_32501_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/10076294/028e86eced79/41598_2023_32501_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/10076294/207964cf8485/41598_2023_32501_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/10076294/c3a32e4f21e9/41598_2023_32501_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/10076294/5f23e23ad6e8/41598_2023_32501_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/10076294/2f6b115bae80/41598_2023_32501_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/10076294/028e86eced79/41598_2023_32501_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/10076294/207964cf8485/41598_2023_32501_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36d2/10076294/c3a32e4f21e9/41598_2023_32501_Fig5_HTML.jpg

相似文献

1
Priority age targets for COVID-19 vaccination in Ethiopia under limited vaccine supply.在疫苗供应有限的情况下,埃塞俄比亚 COVID-19 疫苗接种的优先年龄目标。
Sci Rep. 2023 Apr 5;13(1):5586. doi: 10.1038/s41598-023-32501-y.
2
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.《6-17 岁儿童中 ChAdOx1 nCoV-19(AZD1222)疫苗的安全性和免疫原性:COV006 的初步报告,一项 2 期、单盲、随机、对照试验》
Lancet. 2022 Jun 11;399(10342):2212-2225. doi: 10.1016/S0140-6736(22)00770-X.
3
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
4
Modeling the interplay between demography, social contact patterns, and SARS-CoV-2 transmission in the South West Shewa Zone of Oromia Region, Ethiopia.在埃塞俄比亚奥罗米亚地区西南绍瓦地区,对人口统计学、社会接触模式和 SARS-CoV-2 传播之间的相互作用进行建模。
BMC Med. 2021 Apr 9;19(1):89. doi: 10.1186/s12916-021-01967-w.
5
Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.两剂 ChAdOx1 nCoV-19 疫苗对 COVID-19 住院和死亡的保护作用随时间变化的回顾性、基于人群的队列研究:苏格兰和巴西的研究。
Lancet. 2022 Jan 1;399(10319):25-35. doi: 10.1016/S0140-6736(21)02754-9. Epub 2021 Dec 20.
6
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.一剂接种和加强针接种时间对 ChAdOx1 nCoV-19(阿斯利康)疫苗免疫原性和有效性的影响:四项随机试验的 pooled 分析。
Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19.
7
Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19.BNT162b2 与 ChAdOx1 nCoV-19 疫苗对 COVID-19 的疗效比较。
BMC Med. 2023 Feb 28;21(1):78. doi: 10.1186/s12916-023-02795-w.
8
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840.
9
An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.一项针对风湿和免疫介导性疾病患者的阿根廷队列研究:SARS-CoV-2 疫苗接种:SAR-CoVAC 注册研究方案和初步数据。
Clin Rheumatol. 2022 Oct;41(10):3199-3209. doi: 10.1007/s10067-022-06253-5. Epub 2022 Jun 28.
10
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].《中国季节性流感疫苗接种技术指南(2021—2022年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.

引用本文的文献

1
Comparing the effectiveness of ring and block-vaccination strategies on networks.比较环形和分区接种策略在网络中的有效性。
PLoS Comput Biol. 2025 Aug 11;21(8):e1013274. doi: 10.1371/journal.pcbi.1013274. eCollection 2025 Aug.
2
Exploring affordable and effective pandemic containment measures in lower-income countries with a spatial SEIR model: a case study in South Africa.运用空间SEIR模型探索低收入国家经济适用且有效的疫情防控措施:以南非为例
BMC Public Health. 2025 Jul 23;25(1):2526. doi: 10.1186/s12889-025-23686-0.
3
Learning from the COVID-19 pandemic: A systematic review of mathematical vaccine prioritization models.

本文引用的文献

1
Attitudes towards receiving COVID-19 vaccine and its associated factors among Southwest Ethiopian adults, 2021.2021 年,埃塞俄比亚西南部成年人对 COVID-19 疫苗的态度及其相关因素。
PLoS One. 2023 Jan 23;18(1):e0280633. doi: 10.1371/journal.pone.0280633. eCollection 2023.
2
Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data.基于接触者追踪数据估计 SARS-CoV-2 Alpha 和 Delta 变异株的潜伏期和代际时间。
Epidemiol Infect. 2022 Dec 16;151:e5. doi: 10.1017/S0950268822001947.
3
COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns.
从新冠疫情中学习:数学疫苗优先排序模型的系统综述
Infect Dis Model. 2024 May 15;9(4):1057-1080. doi: 10.1016/j.idm.2024.05.005. eCollection 2024 Dec.
4
Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models.从新冠疫情中学习:数学疫苗优先级模型的系统综述
medRxiv. 2024 Mar 7:2024.03.04.24303726. doi: 10.1101/2024.03.04.24303726.
5
Leveraging COVID-19 Vaccine Safety Monitoring in Ethiopia and Pakistan to Enhance System-Wide Safety Surveillance.利用埃塞俄比亚和巴基斯坦的 COVID-19 疫苗安全监测来加强全系统安全监测。
Glob Health Sci Pract. 2024 Feb 20;12(Suppl 1). doi: 10.9745/GHSP-D-23-00161.
6
Modeling vaccination strategies with limited early COVID-19 vaccine access in low- and middle-income countries: A case study of Thailand.低收入和中等收入国家早期新冠疫苗供应有限情况下的疫苗接种策略建模:以泰国为例
Infect Dis Model. 2023 Nov 15;8(4):1177-1189. doi: 10.1016/j.idm.2023.11.003. eCollection 2023 Dec.
7
COVID-19 vaccine acceptance and associated factors among adult clients at public hospitals in eastern Ethiopia using the health belief model: multicentre cross-sectional study.采用健康信念模型评估埃塞俄比亚东部公立医院成年患者对 COVID-19 疫苗的接受程度及相关因素:一项多中心横断面研究。
BMJ Open. 2023 Mar 23;13(3):e070551. doi: 10.1136/bmjopen-2022-070551.
世卫组织非洲区域 47 个国家的 COVID-19 疫情:对过去趋势和未来模式的建模分析。
Lancet Glob Health. 2022 Aug;10(8):e1099-e1114. doi: 10.1016/S2214-109X(22)00233-9. Epub 2022 Jun 1.
4
COVID-19 vaccine acceptance and its associated factors in Ethiopia: A systematic review and meta-analysis.埃塞俄比亚的新冠疫苗接种接受度及其相关因素:一项系统评价与荟萃分析
Clin Epidemiol Glob Health. 2022 Mar-Apr;14:101001. doi: 10.1016/j.cegh.2022.101001. Epub 2022 Mar 7.
5
Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals, Western Ethiopia: A cross-sectional survey.卫生专业人员对 COVID-19 疫苗接种的态度以及卫生专业人员中与疫苗接种相关的因素:横断面调查。
PLoS One. 2022 Mar 9;17(3):e0265061. doi: 10.1371/journal.pone.0265061. eCollection 2022.
6
The basic reproduction number of COVID-19 across Africa.非洲地区 COVID-19 的基本再生数。
PLoS One. 2022 Feb 25;17(2):e0264455. doi: 10.1371/journal.pone.0264455. eCollection 2022.
7
Global impact of delta plus variant and vaccination.德尔塔plus变种和疫苗接种的全球影响。
Expert Rev Vaccines. 2022 May;21(5):597-600. doi: 10.1080/14760584.2022.2044800. Epub 2022 Feb 28.
8
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.在意大利德尔塔变异株流行期间,mRNA 疫苗对 SARS-CoV-2 感染和重症 COVID-19 的有效性及其保护作用的衰减:回顾性队列研究。
BMJ. 2022 Feb 10;376:e069052. doi: 10.1136/bmj-2021-069052.
9
Equitable access to COVID-19 vaccines makes a life-saving difference to all countries.公平获取 COVID-19 疫苗对所有国家都有着生死攸关的意义。
Nat Hum Behav. 2022 Feb;6(2):207-216. doi: 10.1038/s41562-022-01289-8. Epub 2022 Jan 31.
10
Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China.研究疫苗诱导的免疫及其在中国减轻 SARS-CoV-2 流行中的作用。
BMC Med. 2022 Jan 31;20(1):37. doi: 10.1186/s12916-022-02243-1.